Side-Stepping the Fake Follower Problem with SocialRank's New Tool
In the new era of digital marketing, brands and influencers are scrambling to pile up as many followers as they can, but not all followers are created equal. The quality of followers is in focus now more than ever after a revealing report from The New York Times put the spotlight on the fake follower problem. Alex Taub, Co-Founder & CEO of SocialRank, an online service that enables users to identify, organize, and manage their followers on Twitter and Instagram, was with us to discuss how brands can optimize engagement.
SocialRank just launched a new tool, SocialRank for Content, which let's customers know why a specific post did so well, by analyzing its engagement. Taub explained how this will help brands improve their social media performance. The new product will enable brands and agencies the ability to drop in a tweet or post and generate a SocialRank report based on who has engaged with it.
Comment management on Instagram is a challenge for brands and public figures. SocialRank for Content on Instagram is focused on helping these brands so that they can filter and sort through the comments based on what the accounts said, how big their audience is, and a number of other things. Taub said the company is also working on a tool for finding fake followers.
Seth Schachner, Managing Director at Strat Americas, on Hollywood's latest blockbusters utilizing content creation. Plus, the future of YouTube and TikTok.
Ashley Gold, Axios' Tech/Policy reporter, discusses what the future of Google and search engines will look like after the tech giant faces an antitrust trial.
A labor rights group has alleged that Starbucks sourced coffee from a major Brazilian cooperative whose member farms were cited for keeping workers in slave-like conditions.
X, the social media platform owned by Trump adviser Elon Musk, is challenging the constitutionality of a Minnesota ban on using deepfakes to influence elections and harm candidates.
Seth Goldstein, Equity Strategist at Morningstar, breaks down Tesla's earnings report, talks Musk's future with the company and how stocks have responded.
Senior Health Correspondent for TIME, Alice Park, gives us a deeper look into how Eli Lilly's new pill orforglipron may change the healthcare industry.
Archer Aviation CEO Adam Goldstein talks about the advancements in electric air taxis and how his company is changing the future of air transportation. Watch!
